Neuroscience
Positron Emission Tomography
100%
Beta Amyloid
100%
Amyloid Precursor Protein
100%
Apolipoprotein E
100%
Amyloid Protein
100%
Alzheimer's Disease
96%
Blood Plasma
50%
Metabolic Pathway
20%
In Vivo
16%
Apolipoprotein A1
16%
Proteomics
16%
Acute Phase Protein
16%
Two Dimensional Polyacrylamide Gel Electrophoresis
16%
positron emission tomographic scan
16%
Liquid Chromatography-Mass Spectrometry
16%
In Vitro
10%
Gel Electrophoresis
10%
Amyloid Beta Protein
10%
C-Terminus
10%
Amino Acid
10%
Protein Binding
10%
Biochemistry, Genetics and Molecular Biology
Apolipoprotein E
100%
Amyloid Precursor Protein
100%
Amyloid Protein
100%
Amyloid Beta
100%
Clinical Trial
33%
Blood Plasma
33%
Metabolic Pathway
20%
Cell Lysate
20%
Biomarker Discovery
16%
Tau
16%
Tandem Mass Spectrometry
16%
Apolipoprotein A1
16%
Proteomics
16%
Serum Total Protein
16%
Molecular Weight
16%
Acute Phase Protein
16%
Liquid Chromatography-Mass Spectrometry
16%
Two Dimensional Polyacrylamide Gel Electrophoresis
16%
positron emission tomographic scan
16%
Amino Acids
10%
Beta-Peptide
10%
Isoform
10%
Binding Protein
10%
C-Terminus
10%
Brain Extract
10%
Gel Electrophoresis
10%
Precursor
10%
Immunology and Microbiology
Blood Plasma
100%
Apolipoprotein E
100%
Precursor
100%
Liquid Chromatography Mass Spectrometry
33%
Acute Phase Protein
33%
Tandem Mass Spectrometry
33%
Proteomics
33%
Molecular Weight
33%
Two-Dimensional Gel Electrophoresis
33%
Cerebrospinal Fluid
33%
positron emission tomographic scan
33%
Cell Lysate
18%
Human Cell
9%
Amino Acid
9%
Brain Extract
9%
Peptides
9%
Carboxy Terminal Sequence
9%
Protein Binding
9%
